Association of the catechol-O-methyl transferase gene Val158Met polymorphism with blood pressure and prevalence of hypertension: Interaction with dietary energy intake

American Journal of Hypertension

Volumn 24, Issue 9, 2011, Pages 1022-1026

  Chi Htun, Nay ^a   Miyaki, Koichi ^a,b   Song, Yixuan ^b   Ikeda, Shinobu ^a   Shimbo, Takuro ^b   Muramatsu, Masaaki ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

blood pressure; COMT gene Val158Met polymorphism; dietary energy intake; hypertension

Indexed keywords

CATECHOL METHYLTRANSFERASE; SODIUM CHLORIDE;

ADULT; ARTICLE; BLOOD PRESSURE; CALORIC INTAKE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; FOOD FREQUENCY QUESTIONNAIRE; GENETIC POLYMORPHISM; GENOTYPE; HIGH SODIUM INTAKE; HUMAN; HYPERTENSION; JAPANESE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SODIUM RESTRICTION; SYSTOLIC BLOOD PRESSURE;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; CATECHOL O-METHYLTRANSFERASE; ENERGY INTAKE; HUMANS; HYPERTENSION; JAPAN; LIFE STYLE; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PREVALENCE; SODIUM CHLORIDE, DIETARY;

EID: 80052025365     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1038/ajh.2011.93     Document Type: Article

References (19)

1. Männistö PT, Kaakkola S. Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacol Rev 1999; 51:593-628.
2. Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 1996; 6:243-250. (Pubitemid 26226317)
3. Hosák L. Role of the COMT gene Val158Met polymorphism in mental disorders: a review. Eur Psychiatry 2007; 22:276-281. (Pubitemid 47088199)
4. Hagen K, Pettersen E, Stovner LJ, Skorpen F, Holmen J, Zwart JA. High systolic blood pressure is associated with Val/Val genotype in the catecholo- methyltransferase gene. The Nord-Trøndelag Health Study (HUNT). Am J Hypertens 2007; 20:21-26. (Pubitemid 46014058)
5. Annerbrink K, Westberg L, Nilsson S, Rosmond R, Holm G, Eriksson E. Catechol O-methyltransferase val158-met polymorphism is associated with abdominal obesity and blood pressure in men. Metab Clin Exp 2008; 57:708-711. (Pubitemid 351608233)
6. Kamide K, Kokubo Y, Yang J, Matayoshi T, Inamoto N, Takiuchi S, Horio T, Miwa Y, Yoshii M, Tomoike H, Tanaka C, Banno M, Okuda T, Kawano Y, Miyata T. Association of genetic polymorphisms of ACADSB and COMT with human hypertension. J Hypertens 2007; 25:103-110. (Pubitemid 44885670)
7. Zhang L, Miyaki K, Araki J, Song Y, Kimura T, Omae K, Muramatsu M. Interaction of angiotensin I-converting enzyme insertion-deletion polymorphism and daily salt intake influences hypertension in Japanese men. Hypertens Res 2006; 29:751-758. (Pubitemid 44842809)
8. Tsunoda M, Tenhunen J, Tilgmann C, Arai H, Imai K. Reduced membrane-bound catechol-O-methyltransferase in the liver of spontaneously hypertensive rats. Hypertens Res 2003; 26:923-927. (Pubitemid 37508971)
9. Okuda T, Sumiya T, Iwai N, Miyata T. Pyridoxine 5'-phosphate oxidase is a candidate gene responsible for hypertension in Dahl-S rats. Biochem Biophys Res Commun 2004; 313:647-653. (Pubitemid 38021880)
10. Helkamaa T, Männistö PT, Rauhala P, Cheng ZJ, Finckenberg P, Huotari M, Gogos JA, Karayiorgou M, Mervaala EM. Resistance to salt-induced hypertension in catechol-O-methyltransferase-gene-disrupted mice. J Hypertens 2003; 21: 2365-2374. (Pubitemid 38293577)
11. Stewart SH, Oroszi G, Randall PK, Anton RF. COMT genotype influences the effect of alcohol on blood pressure: results from the COMBINE study. Am J Hypertens 2009; 22:87-91.
12. Ping-I Lin, Jeffery M. Vance, Margaret A. Pericak-Vance, and Eden R. Martin No Gene Is an Island: The Flip-Flop Phenomenon. Am. J. Hum. Genet. 2007;80: 531-538.
13. Savica V, Bellinghieri G, Kopple JD. The effect of nutrition on blood pressure. Annu Rev Nutr 2010; 30:365-401.
14. Zeng C, Eisner GM, Felder RA, Jose PA. Dopamine receptor and hypertension. Curr Med Chem Cardiovasc Hematol Agents 2005; 3:69-77. (Pubitemid 40057733)
15. Kajimoto K, Hiura Y, Sumiya T, Yasui N, Okuda T, Iwai N. Exclusion of the catechol-omethyltransferase gene from genes contributing to salt-sensitive hypertension in dahl salt-sensitive rats. Hypertens Res 2007; 30:459-467. (Pubitemid 46958895)
16. Masuda M, Tsunoda M, Imai K. Low catechol-O-methyltransferase activity in the brain and blood pressure regulation. Biol Pharm Bull 2006; 29:202-205. (Pubitemid 43200883)
17. Hirano Y, Tsunoda M, Shimosawa T, Fujita T, Funatsu T. Measurement of catechol- O-methyltransferase activity in the brain of Dahl salt-sensitive rats. Biol Pharm Bull 2007; 30:2178-2180. (Pubitemid 350097029)
18. Preuss HG, Gondal JA, Lieberman S. Association of macronutrients and energy intake with hypertension. J Am Coll Nutr 1996; 15:21-35. (Pubitemid 26042471)
19. Takahasi K, Yoshimura Y, Kaimoto T, Kunii D, Komatsu T, Yamamoto S. Validation of a food frequency questionnaire based on food groups for estimating individual nutrient intake. Jpn J Nutr 2001; 59:221-232 (in Japanese).